Peritoneal Carcinomatosis Targeting With Tumor Homing Peptides

Molecules - Switzerland
doi 10.3390/molecules23051190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

A Tumor-Penetrating Peptide Enhances Circulation-Independent Targeting of Peritoneal Carcinomatosis

Journal of Controlled Release
Pharmaceutical Science
2015English

NGR Tumor-Homing Peptides: Structural Requirements for Effective APN (CD13) Targeting

Bioconjugate Chemistry
Organic ChemistryBiotechnologyPharmacologyPharmaceutical ScienceBioengineeringBiomedical Engineering
2016English

TumorHoPe: A Database of Tumor Homing Peptides

PLoS ONE
Multidisciplinary
2012English

Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-Induced Immunomodulation

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

A Well Differentiated Neuroendocrine Tumor of the Jejunum With Peritoneal Carcinomatosis: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

Lung Cancer and Peritoneal Carcinomatosis

Oncology Letters
Cancer ResearchOncology
2013English

TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis

Clinical Cancer Research
Cancer ResearchOncology
2008English

Abdominal Sarcoidosis May Mimic Peritoneal Carcinomatosis

Case Reports in Obstetrics and Gynecology
2015English

Synthesis, Identification and in Vivo Studies of Tumor-Targeting Agent Peptide Doxorubicin (PDOX) to Treat Peritoneal Carcinomatosis of Gastric Cancer With Similar Efficacy but Reduced Toxicity

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy